Medpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Medpace (MEDP) PT Raised to $38 at Jefferies; Reiterates Hold
November 1, 2017 8:31 AM EDTJefferies raised its price target on Medpace (NASDAQ: MEDP) to $38.00 (from $34.00) while maintaining a Hold rating following the company's 3Q earnings report. 3Q revenue benefited by ~$1.75M from delayed revenue recognition for work completed in 1H17 but for which the client needed to raise funds.... More
